Related references
Note: Only part of the references are listed.Intratumor Heterogeneity: The Rosetta Stone of Therapy Resistance
Andriy Marusyk et al.
CANCER CELL (2020)
Topological features of integrin adhesion complexes revealed by multiplexed proximity biotinylation
Megan R. Chastney et al.
JOURNAL OF CELL BIOLOGY (2020)
Fibroblast-tumor cell signaling limits HER2 kinase therapy response via activation of MTOR and antiapoptotic pathways
Ioannis K. Zervantonakis et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Exploitation of the chick embryo chorioallantoic membrane (CAM) as a platform for anti-metastatic drug testing
P. Pawlikowska et al.
SCIENTIFIC REPORTS (2020)
The PEAK1-PPP1R12B axis inhibits tumor growth and metastasis by regulating Grb2/PI3K/Akt signalling in colorectal cancer
Chenbo Ding et al.
CANCER LETTERS (2019)
Tumor microenvironment-driven non-cell-autonomous resistance to antineoplastic treatment
Yidi Qu et al.
MOLECULAR CANCER (2019)
DHPS-dependent hypusination of eIF5A1/2 is necessary for TGFβ/fibronectin-induced breast cancer metastasis and associates with prognostically unfavorable genomic alterations in TP53
R. Guth et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2019)
Phenotypic Plasticity: Driver of Cancer Initiation, Progression, and Therapy Resistance
Piyush B. Gupta et al.
CELL STEM CELL (2019)
Drug Resistance in HER2-Positive Breast Cancer Brain Metastases: Blame the Barrier or the Brain?
Sheheryar Kabraji et al.
CLINICAL CANCER RESEARCH (2018)
PEAK1, acting as a tumor promoter in colorectal cancer, is regulated by the EGFR/KRas signaling axis and miR-181d
Lanlan Huang et al.
CELL DEATH & DISEASE (2018)
Quantitative in vivo whole genome motility screen reveals novel therapeutic targets to block cancer metastasis
Konstantin Stoletov et al.
NATURE COMMUNICATIONS (2018)
Validation of miRNA prognostic power in hepatocellular carcinoma using expression data of independent datasets
Adam Nagy et al.
SCIENTIFIC REPORTS (2018)
Pseudopodium-enriched atypical kinase 1 mediates angiogenesis by modulating GATA2-dependent VEGFR2 transcription
Huawei Wang et al.
CELL DISCOVERY (2018)
Overexpression of PEAK1 contributes to epithelial-mesenchymal transition and tumor metastasis in lung cancer through modulating ERK1/2 and JAK2 signaling
Chenbo Ding et al.
CELL DEATH & DISEASE (2018)
Spatially and functionally distinct subclasses of breast cancer-associated fibroblasts revealed by single cell RNA sequencing
Michael Bartoschek et al.
NATURE COMMUNICATIONS (2018)
Reprogramming of stromal fibroblasts by SNAI2 contributes to tumor desmoplasia and ovarian cancer progression
Zongyuan Yang et al.
MOLECULAR CANCER (2017)
Phenotypic heterogeneity of disseminated tumour cells is preset by primary tumour hypoxic microenvironments
Georg Fluegen et al.
NATURE CELL BIOLOGY (2017)
Isoprenylcysteine carboxylmethyltransferase function is essential for RAB4A-mediated integrin β3 recycling, cell migration and cancer metastasis
M. T. Do et al.
ONCOGENE (2017)
Follistatin is a metastasis suppressor in a mouse model of HER2-positive breast cancer
Darcie D. Seachrist et al.
BREAST CANCER RESEARCH (2017)
Niche-localized tumor cells are protected from HER2-targeted therapy via upregulation of an anti-apoptotic program in vivo
Jason J. Zoeller et al.
NPJ BREAST CANCER (2017)
Spatial Proximity to Fibroblasts Impacts Molecular Features and Therapeutic Sensitivity of Breast Cancer Cells Influencing Clinical Outcomes
Andriy Marusyk et al.
CANCER RESEARCH (2016)
The somatic mutation profiles of 2,433 breast cancers refines their genomic and transcriptomic landscapes
Bernard Pereira et al.
NATURE COMMUNICATIONS (2016)
Mcl-1 confers protection of Her2-positive breast cancer cells to hypoxia: therapeutic implications
Muhammad Hasan Bashari et al.
BREAST CANCER RESEARCH (2016)
Identification of a PEAK1/ZEB1 signaling axis during TGFβ/fibronectin-induced EMT in breast cancer
Megan Agajanian et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2015)
Definition of a consensus integrin adhesome and its dynamics during adhesion complex assembly and disassembly
Edward R. Horton et al.
NATURE CELL BIOLOGY (2015)
Highly multiplexed imaging of single cells using a high-throughput cyclic immunofluorescence method
Jia-Ren Lin et al.
NATURE COMMUNICATIONS (2015)
PEAK1 Acts as a Molecular Switch to Regulate Context-Dependent TGFβ Responses in Breast Cancer
Megan Agajanian et al.
PLOS ONE (2015)
Temporal regulation of EGF signalling networks by the scaffold protein Shc1
Yong Zheng et al.
NATURE (2013)
Retreatment with trastuzumab-based therapy after disease progression following lapatinib in HER2-positive metastatic breast cancer
S. Gori et al.
ANNALS OF ONCOLOGY (2012)
Human breast cancer associated fibroblasts exhibit subtype specific gene expression profiles
Julia Tchou et al.
BMC MEDICAL GENOMICS (2012)
KRas Induces a Src/PEAK1/ErbB2 Kinase Amplification Loop That Drives Metastatic Growth and Therapy Resistance in Pancreatic Cancer
Jonathan A. Kelber et al.
CANCER RESEARCH (2012)
Comprehensive molecular portraits of human breast tumours
Daniel C. Koboldt et al.
NATURE (2012)
Treatment of HER2-positive breast cancer: current status and future perspectives
Carlos L. Arteaga et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2012)
Critical role for lysyl oxidase in mesenchymal stem cell-driven breast cancer malignancy
Christelle P. El-Haibi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients
Balazs Gyoerffy et al.
BREAST CANCER RESEARCH AND TREATMENT (2010)
Pseudopodium-enriched atypical kinase 1 regulates the cytoskeleton and cancer progession
Yingchun Wang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Novel anticancer targets: revisiting ERBB2 and discovering ERBB3
Jose Baselga et al.
NATURE REVIEWS CANCER (2009)
The inhibition of tumor cell intravasation and subsequent metastasis via regulation of in vivo tumor cell motility by the tetraspanin CD151
Andries Zijlstra et al.
CANCER CELL (2008)
Stromal gene expression predicts clinical outcome in breast cancer
Greg Finak et al.
NATURE MEDICINE (2008)
Understanding how morphogens work
J. C. Smith et al.
PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES (2008)
Mesenchymal stem cells within tumour stroma promote breast cancer metastasis
Antoine E. Karnoub et al.
NATURE (2007)
Gene expression profiling of cancer progression reveals intrinsic regulation of transforming growth factor-β signaling in ErbB2/Neu-induced tumors from transgenic mice
MD Landis et al.
ONCOGENE (2005)
Share Paper
